miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2.

Int J Mol Sci · 2021 · PMC8538253 · PMID 34681655

Europe PMC DOI

hedged sentence

0.4204

closest p · 8.4× alpha

0.4204

boldest claim

The sentences

showed a trendp = 0.4204not close (p > 0.1)

After miR-542-3p transfection, the mRNA level of LEF1 showed a trend of being elevated ( p = 0.4204) and that of TCF7 was significantly increased ( p < 0.05) ( Figure 7 A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.